# Efficacy of Tazarotene in Treatment of Verruca Plana

> **NCT05314127** · PHASE2 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 80 (estimated)

## Conditions studied

- Warts Flat

## Interventions

- **DRUG:** Tazarotene 0.1% Gel,Top
- **DRUG:** Imiquimod
- **DRUG:** Fluorouracil Cream
- **DRUG:** Petrolatum

## Key facts

- **NCT ID:** NCT05314127
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-15
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05314127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05314127, "Efficacy of Tazarotene in Treatment of Verruca Plana". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05314127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*